デフォルト表紙
市場調査レポート
商品コード
1497623

CRISPR遺伝子編集市場:オファリング、技術、用途、最終用途別-世界予測2024-2030年

CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 191 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
CRISPR遺伝子編集市場:オファリング、技術、用途、最終用途別-世界予測2024-2030年
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

CRISPR遺伝子編集市場規模は2023年に32億5,000万米ドルと推計され、2024年には37億7,000万米ドルに達し、CAGR 16.81%で2030年には96億6,000万米ドルに達すると予測されています。

CRISPR-Cas9と呼ばれるCRISPR遺伝子編集は、遺伝学者や医学研究者がDNA配列の一部を追加、削除、変更することによってゲノムの一部を編集、変更することを可能にする画期的な生化学技術です。この技術は、最もシンプルで汎用性が高く、正確な遺伝子操作法のひとつです。遺伝子疾患の有病率の上昇と個別化医療に対する需要の高まりが、市場成長の要因となっています。さらに、バイオテクノロジーおよび製薬部門による研究開発への多額の投資、遺伝子編集アプリケーションに対する政府および規制当局の支援が、市場開拓を促進する上で重要な役割を果たしています。しかし、オフターゲット効果、ヒト生殖系列編集をめぐる倫理的懸念、環境における意図しない結果の可能性は、市場の成長を制限する重大な問題です。さらに、作物設計による精密農業の進展や、細胞および遺伝子研究手法の強化は、市場成長の有利な機会を生み出しています。

主な市場の統計
基準年[2023] 32億5,000万米ドル
推定年[2024] 37億7,000万米ドル
予測年 [2030] 96億6,000万米ドル
CAGR(%) 16.81%

地域別の洞察

南北アメリカ、特に米国とカナダでは、遺伝性疾患と慢性疾患の有病率が高いため、CRISPR技術の進歩に大きな重点が置かれています。消費者のニーズは個別化医療とCRISPRによる新規治療の可能性に集中しています。米国はCRISPR特許の最前線にあり、バイオテクノロジー大手や権威ある学術機関が注目すべき調査を行っています。欧州連合(EU)諸国は、バイオテクノロジーの応用を指導する強固な規制の枠組みを持っており、消費者のニーズと購買行動の両方に影響を与えています。厳しい規制の存在は、一方で徹底的で安全な開発を促すが、他方では技術革新と採用を遅らせる可能性があります。中東・アフリカ地域では、CRISPR技術はまだ導入の初期段階にあります。経済発展やヘルスケア・インフラのレベルが異なるため、消費者のニーズや顧客行動はこれらの地域によって大きく異なります。アジア太平洋地域は、CRISPR遺伝子編集にとって多様で急速に発展している市場です。中国では、CRISPR技術が国や民間から大規模な投資を受けており、特に医療と農業において実質的な研究と応用を推進しています。日本はこの分野への強力な投資を行っており、その技術的進歩と、遺伝子組換えに対する社会的懸念に配慮した規制との整合性を図っています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、CRISPR遺伝子編集市場におけるベンダーの市場ポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。

市場シェア分析

市場シェア分析は、CRISPR遺伝子編集市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、CRISPR遺伝子編集市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 遺伝性疾患に対する新たなワクチンと治療法の必要性が高まる
      • バイオテクノロジーおよび製薬分野への民間および公的投資の増加
      • 宇宙探査におけるCRISPR遺伝子編集の採用
    • 抑制要因
      • CRISPR療法の高コスト
    • 機会
      • CRISPR遺伝子編集の進歩と改善
      • 農業分野におけるCRISPR遺伝子編集の潜在的な用途
    • 課題
      • CRISPR遺伝子編集に関連する技術的な課題と倫理的な懸念
  • 市場セグメンテーション分析
    • テクノロジー:RNA操作を伴うアプリケーションにおけるCRISPR/Cas13の好感度が増加
    • 最終用途:医薬品およびバイオテクノロジー企業における治療法開発および創薬におけるCRISPR遺伝子編集の重要性の高まり
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 CRISPR遺伝子編集市場:提供別

  • 試薬・消耗品
  • サービス
  • ソフトウェアとシステム

第7章 CRISPR遺伝子編集市場:技術別

  • 抗CRISPRタンパク質
  • クリスパー/Cas13
  • クリスパー/Cas9
  • CRISPR/Cpf1(Cas12a)

第8章 CRISPR遺伝子編集市場:用途別

  • 診断と治療の開発
  • 遺伝子工学

第9章 CRISPR遺伝子編集市場:最終用途別

  • 学術調査機関
  • 製薬・バイオテクノロジー企業

第10章 南北アメリカのCRISPR遺伝子編集市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のCRISPR遺伝子編集市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのCRISPR遺伝子編集市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • SynthegoとSeQure Dxが提携し、CRISPRベースの治療薬開発者向けに包括的なオフターゲット解析サービスを提供
    • CRISPR QC、シリーズA資金調達ラウンドで1,000万米ドルを調達
    • 新興企業Tomeが2億5,000万米ドルの遺伝子編集取引でReplace TXを買収
  • 戦略分析と提言

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR GENE EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CRISPR GENE EDITING MARKET DYNAMICS
  • FIGURE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD
目次
Product Code: MRR-5C6F41F5AF91

[191 Pages Report] The CRISPR Gene Editing Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 16.81% to reach USD 9.66 billion by 2030.

CRISPR gene editing, referred to as CRISPR-Cas9, is a revolutionary biochemical technology that enables geneticists and medical researchers to edit and modify parts of the genome by adding, removing, and altering parts of the DNA sequence. It is one of the simplest, most versatile, and precise methods of genetic manipulation. The rising prevalence of genetic disorders, along with the increasing demand for personalized medicine, is owing to the market growth. Additionally, significant investments in research and development by biotech and pharma sectors and governmental and regulatory support for gene editing applications play a vital role in fostering market development. However, off-target effects, ethical concerns surrounding human germline editing, and the potential for unintended consequences in the environment are significant issues limiting the market growth. Furthermore, the advancement of precision agriculture through crop design and the enhancement of cellular and genetic research methods create lucrative opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.66 billion
CAGR (%) 16.81%

Regional Insights

In the Americas, particularly the United States and Canada, there is a significant emphasis on the advancement of CRISPR technology due to the high prevalence of genetic disorders and chronic diseases. Consumer needs are focused on personalized medicine and the potential of CRISPR to provide novel treatments. The United States is at the forefront in terms of CRISPR patents, with notable research being conducted by biotech giants and prestigious academic institutions. European Union (EU) countries have a robust regulatory framework guiding biotechnology applications that impact both consumer needs and purchasing behavior. The presence of stringent regulations, encouraging thorough, safe development on the one hand but potentially slowing innovation and adoption on the other. In the Middle East and Africa regions, CRISPR technology is still in the nascent stages of adoption. Due to varying levels of economic development and healthcare infrastructure, consumer needs and customer behavior differ significantly across these territories. The Asia Pacific region presents a diverse and rapidly evolving market for CRISPR gene editing. In China, CRISPR technology is receiving massive state and private investment, pushing forward substantial research and applications, especially in medicine and agriculture. Japan demonstrates a strong investment in the field, aligning its technological advancements with regulations sensitive to public concerns about genetic modification.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the CRISPR Gene Editing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing need for new vaccines and treatments for genetic diseases
      • Increasing private and public investments in biotechnological and pharmaceutical sectors
      • Adoption of CRISPR gene editing in space investigation
    • Market Restraints
      • High cost of CRISPR therapies
    • Market Opportunities
      • Advancements and improvements in CRISPR gene editing
      • Potential use of CRISPR gene editing in the agriculture sector
    • Market Challenges
      • Technical challenges and ethical concerns associated with CRISPR gene editing
  • Market Segmentation Analysis
    • Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
    • End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the CRISPR Gene Editing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the CRISPR Gene Editing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers

Synthego and SeQure Dx formed a strategic alliance to advance the development of CRISPR therapeutics. This collaboration equips developers with an all-encompassing off-target editing analytic service, leveraging SeQure Dx's distinguished ONE-seq assay technology and Synthego's robust suite of synthetic guide RNAs. The seamless integration of these offerings promises to streamline the therapeutic development cycle, enhancing safety and efficiency while satisfying stringent regulatory standards. [Published On: 2024-01-23]

CRISPR QC Raises USD 10 Million in Series A Financing Round

CRISPR QC, a startup based in San Diego, concluded a Series A funding round with a significant USD 10 million investment. Specializing in assessing CRISPR/Cas9 gene-editing endeavors, CRISPR QC is pioneering the field with its innovative platform that utilizes the CRISPR-Chip, a high-precision biosensor designed to evaluate CRISPR activity accurately. This funding triumph comes from a seed funding round that garnered USD 1.6 million, reflecting growing confidence and interest in CRISPR QC's potential to transform gene editing quality control. [Published On: 2024-01-05]

Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal

Tome Biosciences announced the acquisition of Replace Therapeutics in a strategic move, accelerating its footprint in the burgeoning gene editing sector. This acquisition underscores Tome's ambition to broaden its disease treatment portfolio and embodies the growing valuation of the gene editing market. Replace's contribution to Tome's suite with its ligase-mediated programmable genomic integration (L-PGI) complements Tome's existing large DNA edits, enhancing the company's capabilities in addressing various genetic conditions with high efficiency and specificity. [Published On: 2024-01-03]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the CRISPR Gene Editing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AstraZeneca PLC, Beam Therapeutics Inc., Bio-Rad Laboratories, Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., F. Hoffmann-La Roche AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Qiagen NV, Sherlock Biosciences, Inc., Thermo Fisher Scientific Inc., and ToolGen, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Reagents & Consumables
    • Services
    • Software & Systems
  • Technology
    • Anti-CRISPR Proteins
    • CRISPR/Cas13
    • CRISPR/Cas9
    • CRISPR/Cpf1 (Cas12a)
  • Application
    • Diagnostics & Therapy Development
    • Genetic Engineering
      • Animal Genetic Engineering
      • Cell Line Engineering
      • Plant Genetic Engineering
  • End-use
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
      • 5.1.1.3. Adoption of CRISPR gene editing in space investigation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CRISPR therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR gene editing
      • 5.1.3.2. Potential use of CRISPR gene editing in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR gene editing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
    • 5.2.2. End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. CRISPR Gene Editing Market, by Offering

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Services
  • 6.4. Software & Systems

7. CRISPR Gene Editing Market, by Technology

  • 7.1. Introduction
  • 7.2. Anti-CRISPR Proteins
  • 7.3. CRISPR/Cas13
  • 7.4. CRISPR/Cas9
  • 7.5. CRISPR/Cpf1 (Cas12a)

8. CRISPR Gene Editing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics & Therapy Development
  • 8.3. Genetic Engineering

9. CRISPR Gene Editing Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas CRISPR Gene Editing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CRISPR Gene Editing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CRISPR Gene Editing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers
    • 13.3.2. CRISPR QC Raises USD 10 Million in Series A Financing Round
    • 13.3.3. Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio